Outcomes in critically ill chronic lymphocytic leukemia patients.

about

Outcomes in adult critically Ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d'Onco-Hématologie (GRRR-OH)

P2860

Q28071353-D913CA0C-8AE7-40AD-B2E7-0E642CB25315

P2860

Outcomes in critically ill chronic lymphocytic leukemia patients.

Item

http://www.wikidata.org/entity/Q44413722

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Outcomes in critically ill chronic lymphocytic leukemia patients.

@en

Outcomes in critically ill chronic lymphocytic leukemia patients.

@nl

type

Item

label

Outcomes in critically ill chronic lymphocytic leukemia patients.

@en

Outcomes in critically ill chronic lymphocytic leukemia patients.

@nl

prefLabel

Outcomes in critically ill chronic lymphocytic leukemia patients.

@en

Outcomes in critically ill chronic lymphocytic leukemia patients.

@nl

P1476

Outcomes in critically ill chronic lymphocytic leukemia patients.

@en

P2093

Aliénor Xhaard

http://www.w3.org/2001/XMLSchema#string

David Schnell

http://www.w3.org/2001/XMLSchema#string

Elie Azoulay

http://www.w3.org/2001/XMLSchema#string

François Vincent

http://www.w3.org/2001/XMLSchema#string

Loic Epelboin

http://www.w3.org/2001/XMLSchema#string

Marion Malphettes

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic lymphocytic leukemia

Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.

Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients.

Immune defects in patients with chronic lymphocytic leukemia.

Infectious complications of chronic lymphocytic leukemia.

Current and investigational therapies for patients with CLL.

Management of infectious complications in patients with chronic lymphocytic leukemia.

P2888

s00520-013-1744-4

P304

1885-1891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-013-1744-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Darmon

Vincent Levy

P577

2013-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23411999

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

Outcomes in critically ill chronic lymphocytic leukemia patients.

about

P2860

P2860

Outcomes in critically ill chronic lymphocytic leukemia patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921